Skip to main content
Caplight Logo









ACTO

ACTO

Private
TorontoEnterprise Softwarehttps://acto.com/

Last Round

Corporate Funding

Sep 12, 2024

Total Funding Raised

$45.33M

Company Overview

ACTO is a life sciences technology company that provides an AI-powered Intelligent Field Excellence platform to enhance the performance of field representatives through training, coaching, and content management.

Sector

Enterprise Software

Verticals

Sales Enablement, NLP & Conversational AI, Workflow Automation, Compliance, Customer Experience

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

life sciences sales enablementpharma sales trainingAI field simulationAI agentsworkflow automationmedical science liaison trainingcommercial excellence platformvertical SaaSAI copilotsales coaching softwarepharma techenterprise AI agentsVeeva integrationsales readinessSaaS marketplace

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ACTO Comparables

Compare ACTO with similar companies based on industry and business-model similarity.

ACTO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SmartWinnr
83%
Quantified
79%
Allego
78%

ACTO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingSep 12, 2024
SeedMar 15, 2024
Series BJul 7, 2022
Series AAug 27, 2020

Key People

Founding team and executive leadership

Ray Newal

Strategic Advisor To CEO

Executive Team

Kumar Erramilli

Chief Technology Officer

Executive Team

Jenny Yeung

Chief Financial Officer

Executive Team

ACTO Investors

Notable investors and investment history

ACTO investors
InvestorRounds
Graphite VenturesCorporate Funding
Maple Leaf AngelsSeed
Panache VenturesCorporate Funding, Series A, Seed, Series B
MaRS Discovery DistrictSeries A, Series B
Questa CapitalCorporate Funding, Series B
Salesforce VenturesSeries A, Series B
Innovation Grade VenturesCorporate Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 13, 2026

    Launched SuperAgents, an AI innovation for Life Sciences professionals.

  • Mar 18, 2026

    Launched AI agents for accelerated Field Excellence in Life Sciences.

Recent news

Latest coverage and updates

  • recognized_asOct 5, 2026

    Everest Group recognizes ACTO Technologies Inc. as a Luminary in its Innovation Watch: Agentic AI in Life Sciences Commercial 2026, placing it among 22 evaluated providers with the strongest market performance and ecosystem drivers on Oct 5th '26 in Ontario and New York.

  • recognized_asOct 5, 2026

    Everest Group positions ACTO Technologies Inc. as a Luminary in its Innovation Watch: Agentic AI in Life Sciences Commercial 2026, recognizing the company alongside strategic partners Veeva and Salesforce.

  • recognized_asSep 14, 2026

    Everest Group recognized ACTO Technologies Inc. among its Top 50(TM) Pharmaceutical Technology Providers for 2026 in Canada and the United States on Sep 14th '26

  • partners_withSep 2, 2026

    ACTO Technologies Inc. will partner with Veeva Systems on Sep 14th '26.

  • recognized_asSep 2, 2026

    ACTO Technologies Inc. achieves Veeva Gold Product Partner status in Canada and New York on Sep 2nd '26

ACTO Filings

Explore SEC and related filing metadata, where available.

ACTO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ACTO's valuation, stock price, and market status.

Is ACTO a public or private company?

ACTO is a private company.

What is the current stock price of ACTO?

ACTO is a private company, so its shares have no public market price. Caplight tracks ACTO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ACTO worth (valuation)?

Valuation information for ACTO is not publicly available.

Can I buy ACTO stock?

ACTO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ACTO's last funding round?

ACTO's most recent funding round was Corporate Funding on September 12, 2024.

Who are the main investors in ACTO?

Key investors in ACTO include Questa Capital, Resolve Growth Partners, Cusp Capital, 468 Capital.

Will ACTO IPO soon?

No public IPO plans have been announced for ACTO.

How can I track ACTO secondary market activity?

Caplight tracks bids, offers, and trades in ACTO's shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range80
Year Founded2014
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?